Government initiatives in autism clinical trials.
Randomized clinical trials remain the most valid method of testing the efficacy and safety of treatments. While efforts to elucidate the genetic and neurodevelopmental bases of autism are underway, clinicians and families are in need of scientifically valid information on how to best treat patients with autism. The effectiveness of many interventions currently used in communities has not been adequately tested. Given the high public health relevance of autism treatment research and the low interest of the pharmaceutical industry in autism, the role of the National Institutes of Health in supporting this research is paramount. Among recently launched initiatives in autism clinical trials, there are the Research Units on Pediatric Psychopharmacology Autism Network and the network of centers for Studies to Advance Autism Research and Treatment. These and other government activities in the area of autism clinical trials are here briefly reviewed.
Vitiello
Benedetto
B
Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, Maryland 20892-9633, USA. bvitiell@mail.nih.gov
Wagner
Ann
A
D001321:Autistic Disorder; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States